Vin-Cent Wu Selected Research

Aldosterone

10/2022	Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.
6/2022	Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data.
5/2022	Aldosterone Suppresses Endothelial Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen Species Pathway.
1/2022	KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma.
1/2022	Radiomics utilization to differentiate nonfunctional adenoma in essential hypertension and functional adenoma in primary aldosteronism.
1/2022	Divergent Characteristics of T-Cell Receptor Repertoire Between Essential Hypertension and Aldosterone-Producing Adenoma.
1/2022	Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
1/2022	A Novel Somatic Mutation of CACNA1H p.V1937M in Unilateral Primary Hyperaldosteronism.
1/2022	Aldosterone suppresses cardiac mitochondria.
1/2022	Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vin-Cent Wu Research Topics

Disease

70	Hyperaldosteronism (Conn Syndrome) 10/2022 - 08/2009
58	Adenoma (Adenomas) 10/2022 - 05/2007
41	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 01/2005
36	Hypertension (High Blood Pressure) 01/2022 - 10/2009
25	Essential Hypertension 01/2022 - 05/2010
17	Fibrosis (Cirrhosis) 06/2022 - 02/2011
14	Chronic Renal Insufficiency 09/2021 - 01/2009
11	Critical Illness (Critically Ill) 11/2022 - 12/2008
11	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 12/2005
10	Neoplasms (Cancer) 10/2022 - 04/2014
10	Sepsis (Septicemia) 02/2022 - 01/2008
9	Heart Failure 12/2021 - 12/2010
7	Inflammation (Inflammations) 05/2022 - 09/2014
7	Hypokalemia 01/2022 - 07/2011
7	Hyperplasia 01/2019 - 10/2009
6	Kidney Diseases (Kidney Disease) 01/2022 - 11/2016
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2016
6	Proteinuria 01/2020 - 01/2011
5	Diabetes Mellitus 06/2022 - 01/2013
5	Renal Insufficiency (Renal Failure) 01/2020 - 10/2006
5	Reperfusion Injury 01/2019 - 07/2013
4	Insulin Resistance 01/2022 - 01/2009
4	Stroke (Strokes) 01/2020 - 01/2015
4	Latent Tuberculosis 10/2016 - 01/2012
3	Infections 02/2022 - 10/2006
3	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 09/2006
3	Necrosis 01/2019 - 08/2010
3	Carcinogenesis 10/2018 - 04/2014
3	Tuberculosis (Tuberculoses) 05/2016 - 01/2012
3	Fever (Fevers) 10/2013 - 04/2003
3	Thrombocytopenia (Thrombopenia) 10/2006 - 12/2002
2	Glucocorticoid-Remediable Aldosteronism 01/2022 - 11/2019
2	Vascular Remodeling 01/2022 - 10/2019
2	Atrial Fibrillation 12/2021 - 06/2020
2	Channelopathies 08/2021 - 06/2015
2	Ischemia 01/2021 - 11/2016
2	Wounds and Injuries (Trauma) 11/2020 - 01/2016
2	Septic Shock (Toxic Shock Syndrome) 06/2020 - 09/2018
2	Familial Hyperaldosteronism 01/2020 - 11/2019
2	Left Ventricular Dysfunction 11/2019 - 09/2014
2	Myocardial Infarction 10/2019 - 09/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018 - 01/2013
2	Status Epilepticus (Complex Partial Status Epilepticus) 11/2015 - 01/2012
2	Iron Overload 03/2014 - 10/2004

Drug/Important Bio-Agent (IBA)

87	AldosteroneIBA 10/2022 - 05/2007
16	PotassiumIBA 12/2021 - 07/2011
15	ReninIBA 06/2022 - 05/2010
13	Mineralocorticoid Receptor AntagonistsIBA 12/2020 - 06/2013
12	Biomarkers (Surrogate Marker)IBA 11/2022 - 10/2004
9	CreatinineIBA 09/2021 - 10/2006
7	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2022 - 05/2007
7	Angiotensin Receptor AntagonistsIBA 01/2022 - 08/2009
6	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 10/2009
6	omega-Chloroacetophenone (Mace)IBA 12/2021 - 01/2016
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 12/2018
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018 - 07/2013
4	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 10/2022 - 11/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 04/2003
4	Lactic Acid (Lactate)FDA LinkGeneric 02/2022 - 01/2008
4	theasinensin AIBA 10/2021 - 12/2017
4	Spironolactone (Aldactone)FDA LinkGeneric 12/2020 - 09/2011
3	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 11/2020
3	Vancomycin FDA LinkGeneric 02/2022 - 01/2009
3	SodiumIBA 01/2021 - 10/2015
3	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2009
3	Interferon-gamma (Interferon, gamma)IBA 10/2016 - 12/2013
3	Losartan (Cozaar)FDA LinkGeneric 09/2016 - 08/2009
3	erucylphosphocholineIBA 01/2015 - 10/2011
3	Serum AlbuminIBA 01/2015 - 01/2012
3	IronIBA 03/2014 - 10/2004
2	methionyl-aspartyl-phenylalaninamide (MAPN)IBA 10/2022 - 01/2022
2	CalciumIBA 01/2022 - 01/2017
2	Cystatin CIBA 09/2021 - 09/2011
2	Fibroblast Growth Factor-23IBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
2	ElectrolytesIBA 06/2020 - 04/2005
2	SteroidsIBA 11/2019 - 01/2006
2	HDL LipoproteinsIBA 10/2018 - 01/2013
2	CateninsIBA 10/2018 - 01/2017
2	AdosterolIBA 07/2018 - 07/2014
2	Therapeutic UsesIBA 09/2017 - 10/2015
2	Bromocriptine (Parlodel)FDA LinkGeneric 09/2017 - 05/2007
2	SaltsIBA 09/2017 - 01/2013
2	Uremic ToxinsIBA 11/2016 - 04/2012
2	IndicanIBA 11/2016 - 07/2013
2	Galectin 3 (LGALS3)IBA 01/2016 - 01/2014
2	C-Reactive ProteinIBA 06/2015 - 10/2013
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2014 - 05/2007

Therapy/Procedure

59	Adrenalectomy 10/2022 - 10/2009
19	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2022 - 12/2005
16	Therapeutics 11/2022 - 04/2003
6	Renal Dialysis (Hemodialysis) 01/2019 - 09/2009
5	Aftercare (After-Treatment) 01/2020 - 10/2009
4	Extracorporeal Membrane Oxygenation 11/2015 - 12/2008
3	Peritoneal Dialysis 01/2019 - 01/2012
3	Nephrectomy 09/2016 - 03/2011
3	Continuous Renal Replacement Therapy 11/2013 - 09/2009
2	Hemoperfusion 06/2020 - 01/2012
2	Cardiopulmonary Resuscitation (CPR) 10/2014 - 09/2009